Lower-limb arterial disease

Lancet

Volumn 350, Issue 9089, 1997, Pages 1459-1465

  Golledge, Jonathan ^a,b  

^a BEDFORD HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; HEPARIN; KETANSERIN; NAFTIDROFURYL; PENTOXIFYLLINE;

AMPUTATION; ANGIOGRAPHY; ANKLE PRESSURE; ARTERY DISEASE; BALLOON DILATATION; CEREBROVASCULAR DISEASE; DOPPLER FLOWMETRY; ECHOGRAPHY; HUMAN; IMAGING; INTERMITTENT CLAUDICATION; ISCHEMIC HEART DISEASE; KINESIOTHERAPY; LEG; LEG ISCHEMIA; LEG REVASCULARIZATION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

EID: 0031583733     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)07421-7     Document Type: Article

References (49)

1. Fowkes FGR. Epidemiology of atherosclerotic arterial disease in the lower limbs. Eur J Vasc Surg 1988; 2; 283-91.
2. Kannel WB, Shurtleff D. The Framingham study: cigarettes and the development of intermittent claudication. Geriatrics 1973; 28; 61-68.
3. Hughson WG, Mann JI, Garrod A. Intermittent claudication: prevalence and risk factors. BMJ 1978; i: 1379-81.
4. Reunanen A, Takkunen H, Aromaa A. Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand 1982; 211: 249-56.
5. Lowe GDO. Conservative management of chronic occlusive arterial disease. In: Galland RB, Clyne CAC, eds. Clinical problems in vascular surgery. London: Edward Arnold, 1994.
6. The Vascular Surgical Society of Great Britain and Ireland. Critical limb ischaemia: management and outcome - report of a national survey. Eur J Vasc Endovasc Surg 1995; 10: 108-13.
7. Hertzer NR. Fatal myocardial infarction following lower extremity revascularisation - 273 patients followed 6-11 postoperative years. Ann Surg 1981; 193: 492-98.
8. Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996; 25: 1172-81.
9. Dormandy JA, Murray GD. The fate of the claudicant: a prospective study of 1969 claudicants. Eur J Vasc Surg 1991; 5: 131-33.
10. Lepantalo M, Matzke S. Outcome of unreconstructed chronic critical leg ischaemia. Eur J Vasc Endovasc Surg 1996; 11: 153-57.
11. Tyrrell MR, Wolfe JHN. Critical leg ischaemia: an appraisal of clinical definitions. Br J Surg 1993; 80: 177-80.
12. Leng GC, Whyman MR, Donnan PT, et al. Accuracy and reproducibility of duplex ultrasonography in grading femoropopliteal stenoses. J Vasc Surg 1993; 17: 510-17.
13. Kaufman SL, Chang R, Kadir S, Mitchell SE, White PI. Intra-arterial digital subtraction angiography in diagnostic arteriography. Radiology 1984; 151: 323-27.
14. Pemberton M, Nydahl S, Hartshorne T, et al. Can lower limb vascular reconstruction be based on colour duplex imaging alone? Eur J Vasc Endovasc Surg 1996; 12: 452-54.
15. Beard JD, Scott DJA, Evans JM, Skidmore R, Horrocks M. Pulse generated runoff: a new method of determining calf vessel patency. Br J Surg 1988; 75: 361-63.
16. Baum RA, Rutter CM, Sunshine JH, et al. Multicentre trial to evaluate vascular magnetic resonance angiography of the lower extremity. JAMA 1995; 274: 875-80.
17. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. BMJ 1994; 308: 81-106, 159-68.
18. Duprez D, Clements DL. Medical treatment of peripheral vascular disease: good or bad? Eur Heart J 1992; 13: 149-51.
19. Cameron HA, Waller PC, Ramsey LE. Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985. Br J Clin Pharmacol 1988; 26: 569-76.
20. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. JAMA 1995; 274: 975-80.
21. Perkins JST, Collin J, Creasy TS, Fletcher EWL, Morris PJ. Exercise training versus angioplasty for stable claudication: long and medium term results of a prospective randomised trial. Eur J Vasc Endovasc Surg 1996; 11: 409-13.
22. Tielbeek AV, Rietjens E, Buth J, Vroegindeweij D, Schol FPJ. The value of duplex surveillance after endocascular intervention for femoropopliteal obstructive disease. Eur J Vasc Endovasc Surg 1996; 12: 145-50.
23. Whyman MR, Fowkes FGR, Kerracher EMG, et al. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication. Eur J Vasc Endovasc Surg 1996; 12: 167-72.
24. Whyman MR, Fowkes FGR, Kerracher EMG, et al. Intermittent claudication is not improved by percutaneous transluminal angioplasty: a randomised controlled trial. Br J Surg 1997; 84: 571 (abstr).
25. Fisher CNM, Fletcher JP, May J, et al. No additional benefit from laser in balloon angioplasty of the superficial femoral artery. Eur J Vasc Endovasc Surg 1996; 11: 349-52.
26. Bosch JL, Hunink MGM. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997; 204: 87-96.
27. Raptis S, Faris I, Miller J, Quigley F. The fate of the aortofemoral graft. Eur J Vasc Endovasc Surg 1995; 9: 97-102.
28. Naji A, Barker CF, Berkowitz HD, Chu J, Roberts B. Femoropopliteal vein grafts for claudication analysis of 100 consecutive cases. Ann Surg 1978; 188: 79-82.
29. Hunink MGM, Wong JB, Donaldson MC, et al. Revascularization for femoropopliteal disease: a decision and cost-effectiveness analysis. JAMA 1995; 274: 165-71.
30. Wolfe JHN, Wyatt MG. Critical and subcritical ischaemia. Eur J Vasc Endovasc Surg 1997; 13: 578-82.
31. Golledge J, Galland RB. Lower limb intra-arterial thrombolysis. Postgrad Med J 1995; 71: 146-50.
32. Jivig-ard L, Berqvist D, Holm J. When is urgent revascularization unnecessary for acute lower limb ischaemia? Eur J Vasc Endovasc Surg 1995; 9: 448-53.
33. Hess H, Ingrisch H, Mietaschk A, Rath H. Local low-dose thrombolytic therapy of peripheral arterial occlusions. N Engl J Med 1982; 307: 1627-30.
34. Weaver FA, Comerota AJ, Youngblood M, et al. Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. J Vasc Surg 1996; 24: 513-23.
35. Ouriel K, Veith FJ, Sansahara AA. Thrombolysis or peripheral arterial surgery: phase I results. J Vasc Surg 1996; 23: 64-75.
36. Cheshire NJ, Wolfe JHN. Does distal revascularization for limb salvage work? In: Greenhalgh RM, Fowkes FGR, eds. Trials and tribulations of vascular surgery. London: WB Saunders, 1996: 353-64.
37. Tunis SR, Bass EB, Steinberg EP. The use of angioplasty, bypass surgery and amputation in the management of peripheral vascular disease. N Engl J Med 1991; 325: 556-62.
38. Pell JP, Fowkes FGR, Lee AJ. Indications for arterial reconstruction and major amputation in the management of chronic critical lower limb ischaemia. Eur J Vasc Endovasc Surg 1997: 13: 315-21.
39. Stanley B, Teague B, Raptis S, Taylor DJ, Berce M. Efficacy of balloon angioplasty of the superficial femoral artery and popliteal artery in the relief of leg ischaemia. J Vasc Surg 1996; 23: 679-85.
40. Varty K, Nydahl S, Bolia A, Bell PRF, London N JM. Surgery or angioplasty for critical limb ischaemia. Br J Surg 1997; 84 (suppl 1): 1 (abstr).
41. The Vascular Surgical Society of Great Britain and Ireland. Recommendations for the management of chronic critical lower limb ischaemia. Eur J Vasc Endovasc Surg 1996; 12: 131-35.
42. Dormandy J, Belcher G, Boccalon H, et al. Controlled randomised study of an oral prostacyclin analogue (Iloprost) in patients with inoperable stage III and IV leg ischaemia. Br J Surg 1996; 83: 557 (abstr).
43. Rutherford RB, Jones DN, Bergentz SE, et al. The efficacy of dextran 40 in preventing early postoperative thrombosis following difficult lower extremity bypass. J Vasc Surg 1984; 1: 764-73.
44. Kretschmer G, Herbst F, Prager M, et al. A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis. Arch Surg 1992; 127; 1112-15.
45. Ouriel K, Green RM, DeWeese JA, Cimino C. Activated protein C resistance: prevalence and implications in peripheral vascular disease. J Vasc Surg 1996; 23: 46-52.
46. Clowes AW, Reidy MA. Prevention of stenosis after vascular reconstruction: pharmacologic control of intimal hyperplasia. J Vasc Surg 1991; 13: 885-91.
47. Ludwig S, Rapp UR. Cascading towards vascular disorder gene therapy. Nat Med 1995; 1: 513-15.
48. Channon KM, Blazing MA, Shetty GA, Potts KE, George SE. Adenoviral gene transfer of nitric oxide synthase: high level expression in human vascular cells. Cardiovasc Res 1996; 32: 962-72.
49. von der Leyen HE, Gibons GH, Morishita R, et al. Gene therapy inhibiting neointimal vascular lesions: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 1995; 92: 1137-41.